15 insiders reported 21 Form 4 transactions for SpringWorks Therapeutics, Inc. (SWTX) over the past 18 months (most recent 2025-07-02). Recent activity: Islam Saqib (Chief Executive Officer) Sell 954,869 shares, Ashar Bhavesh (Chief Commercial Officer) Sell 62,053 shares, Nofi Michael (Chief Accounting Officer) Sell 30,623 shares, Edris Badreddin (Chief Operating Officer) Sell 169,712 shares, Hambleton Julie (Director) Sell 14,155 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-02 | Islam Saqib | Chief Executive Officer | Sell | 954,869 | $0 |
| 2025-07-02 | Ashar Bhavesh | Chief Commercial Officer | Sell | 62,053 | $0 |
| 2025-07-02 | Nofi Michael | Chief Accounting Officer | Sell | 30,623 | $0 |
| 2025-07-02 | Edris Badreddin | Chief Operating Officer | Sell | 169,712 | $0 |
| 2025-07-02 | Hambleton Julie | Director | Sell | 14,155 | $0 |
| 2025-07-02 | ALBAN CARLOS | Director | Sell | 28,861 | $0 |
| 2025-07-02 | Weinstein Herschel S | General Counsel & Secretary | Sell | 55,239 | $0 |
| 2025-07-02 | MACKAY MARTIN | Director | Sell | 20,023 | $0 |
| 2025-07-02 | Lewis-Hall Freda C | Director | Sell | 24,727 | $0 |
| 2025-07-02 | Perier Francis I Jr | Chief Financial Officer | Sell | 60,889 | $0 |
| 2025-07-02 | Pichl Daniel | Chief People Officer | Sell | 50,762 | $0 |
| 2025-07-02 | Fuhrman Alan | Director | Sell | 24,727 | $0 |
| 2025-07-02 | Lin Tai-An | Chief Scientific Officer | Sell | 33,039 | $0 |
| 2025-07-02 | Cassidy James | Chief Medical Officer | Sell | 81,731 | $0 |
| 2025-07-02 | LYNCH DANIEL | Director | Sell | 93,004 | $0 |
| 2025-05-15 | Fuhrman Alan | Director | Buy | 10,060 | $0 |
| 2025-05-15 | LYNCH DANIEL | Director | Buy | 10,060 | $0 |
| 2025-05-15 | ALBAN CARLOS | Director | Buy | 10,060 | $0 |
| 2025-05-15 | MACKAY MARTIN | Director | Buy | 10,060 | $0 |
| 2025-05-15 | Lewis-Hall Freda C | Director | Buy | 10,060 | $0 |
| 2025-05-15 | Hambleton Julie | Director | Buy | 10,060 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-07-02